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Lifelong functional plasticity of the gastrointestinal (GI) tract is essential for health, yet 39 
the underlying molecular mechanisms are poorly understood. The enteric nervous 40 
system (ENS) regulates all aspects of the gut function, via a range of neurotransmitter 41 
pathways, one of which is the GABA-GABAA receptor (GABAAR) system. We have 42 
previously shown that GABAA receptor subunits are differentially expressed within the 43 
ENS and are involved in regulating various GI functions. We have also shown that 44 
these receptors are involved in mediating stress-induced colonic inflammation. 45 
However, the expression and function of intestinal GABAARs, at different ages, is 46 
largely unexplored and was the focus of this study. Here we show that the impact of 47 
GABAAR activation on colonic contractility changes from early postnatal period 48 
through to late adulthood, in an age-dependant manner. We also show that the highest 49 
levels of expression for all GABAAR subunits is evident at postnatal day (P) 10 apart 50 
from the α3 subunit which increased with age. This increase in the α3 subunit 51 
expression in late adulthood (18 months old) is accompanied by an increase in the 52 
expression of inflammatory markers within the mouse colon. Finally, we demonstrate 53 
that the deletion of the α3 subunit prevents the increase in the expression of colonic 54 
inflammatory markers associated with healthy ageing. Collectively, the data provide 55 
the first demonstration of the molecular and functional plasticity of the GI GABAAR 56 
system over the course of a lifetime, and its possible role in mediating the age-induced 57 
colonic inflammation associated with healthy ageing. 58 
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1 Introduction 70 
The integrity of the mammalian gastrointestinal tract (GIT) is fundamental for nutrition 71 
and barrier function over the course of a lifetime. The GIT exhibits remarkable plasticity 72 
during development and the ageing process, despite the changing nutritional needs of 73 
the individual, or the local environment in the form of microbiota and immune function 74 
(1). Nevertheless, ageing is associated with a general decline in intestinal function, 75 
manifesting in motility disorders such as constipation, or altered immune function, such 76 
as inflammation (2). However, the molecular mechanisms underlying this age-related 77 
GI plasticity and the ensuing associated disorders have yet to be fully understood (3). 78 
Age-specific changes in the intrinsic nervous system of the GIT, namely the enteric 79 
nervous system (ENS) and its associated neurotransmitters systems are most likely 80 
central to lifelong GI health (4).  81 
 82 
The ENS is integral to all aspects of coordinated GI function (5, 6). It is a large 83 
collection of neurochemically diverse neurons (7, 8) located within the submucosal 84 
layer and muscle wall of the GIT. These neurons form intricate cellular networks with 85 
neuronal and non-neuronal cell-types and provide the intrinsic neural control of 86 
virtually all GI functions such as peristalsis (9), secretion (10), barrier function (11, 12) 87 
and local immune function (13-15). Despite our considerable insight into ENS-88 
mediated GI function in adulthood, relatively less is known about how this differs 89 
throughout the process of ageing, from early postnatal days to late adulthood. The 90 
most consistent finding in the aged ENS is altered local immune function (16) and 91 
degeneration of neurochemically-distinct cell-types (4, 17, 18). However, there is 92 
considerably less known about the age-related changes in the neurotransmitter 93 
receptor systems through which different ENS neurons mediate their effects on the 94 
GIT. One of these neurotransmitter-receptor systems, the GABA-GABAAR system has 95 
been shown to be involved in virtually all ENS-mediated GI functions (19).  96 
 97 
GABAARs are chloride permeable integral membrane ion channels composed of five 98 
interacting subunit proteins which mediate the rapid effects of the neurotransmitter 99 
GABA (20). While only five subunits are required to form a functional receptor, up to 100 
nineteen molecularly distinct GABAAR subunits (α1-6; β1-3; γ1-3; δ; ε; ρ) have been 101 
identified,  which underpin the expression of ~ 20-30 main distinct GABAAR isoforms 102 
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(21). Within the central nervous system, these receptor subtypes display a differential 103 
regional expression or cellular location (22) and exhibit specific physiological (20) and 104 
pharmacological properties (23). Previous studies in adult animals indicate that the 105 
GABA-GABAAR system directly alters the excitability of ENS neurons (24), 106 
spontaneous colonic contractility (25-27) and GI motility (28, 29). However, the 107 
expression and functional plasticity of this neurotransmitter system at different 108 
maturational stages of the colon, is largely unexplored. Furthermore, we have recently 109 
reported that different GABAAR subtypes have contrasting effects on stress-induced 110 
colonic inflammation (30). Given the consistent finding of altered immune function in 111 
the elderly, that may give rise to colonic inflammation (31), the question arises whether 112 
GABAARs may be associated. In the current study, we show that the force and 113 
frequency of native spontaneous colonic contractions change significantly during early 114 
postnatal development stages. Furthermore, colonic GABAAR expression changes 115 
dramatically in a subunit and age-dependent manner. Finally, the deletion of the 116 






















2 Materials and methods  137 
All procedures involving animal experiments were approved by the Animal Welfare 138 
and Ethical review body of the University of Portsmouth and were performed by a 139 
personal license holder, under a Home Office-issued project licence, in accordance 140 
with the Animals (Scientific Procedures) Act, 1986 (UK) and associated procedures. 141 
 142 
2.1 Animals  143 
For wild-type (WT) mice, the C57BL/6J strain obtained from the University of 144 
Portsmouth Bioresources centre was used. In some experiments, GABAAR α3 subunit 145 
gene deleted (α3 KO) mice, on a C57/BL6J background, were also used. For such 146 
experiments, WT littermates of the α3 KO mice were used as controls. The generation 147 
of these mice has been previously described (32). Animals were bred in-house in a 148 
temperature and humidity controlled environment under a 12-hr light/dark cycle, with 149 
free access to standard chow and water.  150 
 151 
2.2 Isometric tension recordings of the effects of ageing and the GABAAR ligand 152 
alprazolam on the force and frequency of spontaneous contractions in isolated 153 
mouse colon segments 154 
Isometric tension recordings of isolated mouse colon were performed according to our 155 
previously published protocols (27, 33). Mice aged postnatal day 10 (P10), P15, P60 156 
and 18 months old were killed by cervical dislocation. The distal colon removed and 157 
immediately placed in physiological solution containing (mM): NaCl 140, NaHCO3 158 
11.9, D+ glucose 5.6, KCl 2.7, MgCl2.6H2O 1.05, NaH2PO4.2H2O 0.5, CaCl2 1.8, 159 
warmed to 37°C. The intraluminal contents were removed by gently flushing the colon 160 
with physiological solution. Approximately 2 cm long segments were mounted in a 161 
Harvard organ bath (10 ml chamber) filled with physiological solution (37oC) and 162 
bubbled with gas containing 95% O2 and 5% CO2. Contractile activity for each colon 163 
tissue segment was recorded using an isometric force transducer (range 0-25 g) 164 
connected to a bridge amplifier, which was in turn connected to a dedicated data 165 
acquisition system (Power Lab 2.20 AD Instruments). The sampling frequency was 166 
set to 40 Hz and the sensitivity of recording was set to 500 mV. The apparatus was 167 
then calibrated using a one gram weight in order to express changes in the amplitude 168 
detected by the transducer into grams of force. At this stage, in order to assess the 169 
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noise produced by the electrical equipment and as an experimental control, a piece of 170 
cotton was tied to the tissue hook placed in an aerated organ bath at one end and the 171 
other end was passed through the transducer which picked up any movement in the 172 
piece of cotton due to noise. This was represented on the computer as a trace with 173 
peaks up to maximum of 0.02 grams of tension. Therefore in any subsequent analysis 174 
of colonic contractility, any peak less than 0.02 grams of force was disregarded, 175 
thereby revealing only intrinsic  spontaneous contractions. The tissue was then placed 176 
under 1 gram of resting tension and allowed to equilibrate for 30 minutes. The AD 177 
instrument lab chart 7 program was installed on a PC in order to monitor, record and 178 
analyse the activity. After a stable baseline was established, 1 µM flumazenil (Tocris 179 
Bioscience; 1328) or 10 µM alprazolam (Sigma-Aldrich; A8800) was added to the bath 180 
and the tissue was allowed to reach maximum response. We measured the time it 181 
takes to achieve a full response on contractile activity using alprazolam. We observed 182 
full response by 10 minutes after adding alprazolam. Therefore, ten minute epochs 183 
before and after the drug additions were used for quantification of the drug-induced 184 
changes in the force and frequency of colonic spontaneous contractions. One piece 185 
of tissue was used per animal. The frequency and amplitude of individual spontaneous 186 
contractions was calculated on LabChart Reader software by measuring the difference 187 
between the baseline and the peak of every individual contraction. This value was then 188 
subtracted from the noise level 0.02 g in order to account for the electrical noise 189 
produced by equipment. This was done for the all the contraction before and after the 190 
drug additions and the average for that animal was determined. Due to differences in 191 
the patterns of colonic spontaneous contractions across ages we were unable to 192 
separate large amplitude contractions from smaller oscillations. Therefore, there data 193 
presented in the paper are an average of both large and smaller spontaneous 194 
contractions together. The mean value for each animal was then normalised against 195 
the weight of the tissue used in the experiment. A mean value for the individual 196 
averages was then obtained for a particular drug. In addition, the effect of 10 µM 197 
alprazolam on the basal tone of the tissue was also determined. An N value thus 198 




2.3 Quantitative reverse transcription Polymerase Chain Reaction (qPCR)  201 
qPCR performed on colon tissue was carried out according to our previously published 202 
protocols (34). Mice aged P10, P15, P60 and 18 months were killed by cervical 203 
dislocation and tissue homogenates of the whole colon prepared. RNA was extracted 204 
from the samples using a RNeasy mini kit (Qiagen, 74104) according to the 205 
manufacturer’s protocol. Equal amounts of RNA from each tissue was reverse-206 
transcribed into first-strand cDNA in the following reaction: 2 µl of reverse transcription 207 
buffer (BioLabs), 1 µl of oligo(dT) (ThermoFisher Scientific), 1µ dNTP (ThermoFisher 208 
Scientific), 0.5 µl of M-MuLV reverse transcriptase (Applied Biosystems) and 0.5 µl of 209 
RiboLock (ThermoFisher Scientific). The reactions were then made up to 20 µl with 210 
nuclease free-PCR grade water. qPCR amplification was performed in 96-well plates 211 
in a mastermix for probes (Roche, Burgess Hill, UK) and run on a LightCycler® 96 212 
System (Roche). The qPCR amplifications for the mouse Gabra1 (assay ID: 213 
Mm00439046_m1), Gabra2 (assay ID: Mm00433435_m1), Gabra3 (assay ID: 214 
Mm01294271_m1), Gabra4 (assay ID: Mm00802631_m1), Gabra5 (assay ID: 215 
Mm00621092_m1), Gabrg2 (assay ID: Mm00433489_m1), CD163 (assay ID: 216 
Mm00474091_m1) and TNFα (assay ID: Mm00443258_m1) genes were performed 217 
using pre-designed Taqman primers/probes purchased from Life Technologies 218 
(ThermoFisher scientific). Gapdh (assay ID: Mm99999915_g1) gene expression was 219 
used as the housekeeping gene in every reaction. The qPCR cycling conditions 220 
entailed 95°C for 10 mins and 40 cycles of 95°C for 15 sec and 60°C for 60 sec 221 
(LightCycler® 96 System, Roche). Standard curves were generated for each gene 222 
using serial dilutions of a known amount of mRNA which was then reverse transcribed 223 
into cDNA. Each measurement was performed in duplicate and each Ct value was 224 
then converted into ng mRNA using linear regression analysis of the standard curve 225 
(Microsoft Excel). Each ng mRNA value was then normalised against the ng 226 
housekeeping gene level within the same sample and the mean mRNA levels for every 227 
sample was finally calculated and compared across all experimental groups. 228 
 229 
2.4 Immunohistochemistry and confocal microscopy 230 
Mice were anaesthetised first with isoflurane and then pentobarbitone (1.25 mg/kg of 231 
bodyweight; i.p.), transcardially perfused first with 0.9% saline and then a fixative 232 
containing 1% w/v paraformaldehyde and 15% v/v saturated picric acid in 0.1 M 233 
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phosphate buffer (pH 7.4) according to previously described protocols (35). After 234 
perfusion, the colons were removed and post-fixed in the same fixative over night at 235 
4o C. The next day, the tissue was washed in 0.1 M phosphate buffer until it was clear 236 
of the fixative. Whole-mount preparations of the longitudinal muscle-myenteric plexus 237 
and circular muscle-submucosal plexus were obtained using a dissecting microscope 238 
and fine forceps, which were then stored in 0.1 M phosphate buffer containing 0.05% 239 
w/v sodium azide. Staining for the inflammatory marker CD163 on whole-mount 240 
preparations of the colon was performed as described in our previously published 241 
protocols (36). Briefly, non-specific binding of secondary antibodies was blocked by 242 
incubating the tissue with 20% v/v normal horse serum for 2 hours at room 243 
temperature. The tissue was incubated with cocktails of the following primary 244 
antibodies: 1) rabbit anti-CD163, 1:250 (Santa Cruz; sc-33560); 2) sheep anti-nitric 245 
oxide synthase, 1:1000 (Millipore; AB1529), diluted in Tris buffer saline containing 246 
0.3% w/v Triton X-100 (TBS-Tx) and 20% v/v normal horse serum, overnight at 4°C. 247 
After washing with TBS-Tx, the tissue was incubated in a mixture of appropriate 248 
secondary antibodies conjugated with either Alexa Fluor 488 (Invitrogen, Eugene, OR) 249 
and indocarbocyanine (Cy3; Jackson ImmunoResearch) for 2 hours at room 250 
temperature. The tissue was washed in TBS-Tx and mounted on glass slides in Mowiol 251 
mounting medium (Polysciences) and then cover slipped. Sections were examined 252 
with a confocal laser-scanning microscope (LSM710; Zeiss, Oberkochen, Germany) 253 
using either a Plan Apochromatic 40x DIC oil objective (NA1.3) (pixel size 0.29 μm), a 254 
Plan Apochromatic 63x DIC oil objective (NA1.4) (pixel size 0.13 μm) or a Plan 255 
Apochromatic 100x DIC oil objective (NA1.46) (pixel size 0.08 μm). All images 256 
presented represent a single optical section. These images were acquired using 257 
sequential acquisition of the different channels to avoid cross-talk between 258 
fluorophores, with the pinholes adjusted to one airy unit. Images were processed with 259 
the software Zen2008 Light Edition (Zeiss, Oberkochen, Germany) and exported into 260 
Adobe Photoshop. Only brightness and contrast were adjusted for the whole frame, 261 
and no part of a frame was enhanced or modified in any way. 262 
 263 
2.5 Quantification of CD163-immunopositive cell density 264 
Multiple fields of view were imaged from each piece of tissue and the number of 265 
CD163-immunopositive cells were manually counted in each field of view using the 266 
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Image J software cell count analysis function. The average of all fields of view was 267 
calculated for each piece of tissue and considered as N = 1. One piece of tissue was 268 
used per animal. 269 
 270 
2.6 Statistical analysis 271 
All statistical analyses were performed using GraphPad Prism 7 (GraphPad Inc. La 272 
Jolla, CA). Animals were randomly assigned to treatment groups. All results are 273 
expressed as mean ± SEM. Statistical comparisons between different animal groups 274 
and treatments were assessed using the appropriate statistical tests, indicated in the 275 





3 Results 279 
3.1 Spontaneous colonic contractions and their degree of modulation by GABAARs, 280 
changes dynamically with age 281 
We first characterised the changes in the force and frequency of spontaneous colonic 282 
contractions, at P 10, 15, 60 and 18 months. We then investigated the impact of 283 
GABAAR activation on spontaneous colonic contraction across these ages. There 284 
were striking differences in the patterns of spontaneous colonic contractility across all 285 
ages investigated (Fig. 1 A). Quantification of the force of spontaneous contractions 286 
revealed significant differences at different ages (p < 0.0001, one way ANOVA, N = 8 287 
animals per age group). Post-hoc analysis revealed a significant decrease in the force 288 
of spontaneous contractions between P 10 and P 15 (p < 0.0001, Tukey’s), and P 60 289 
(p < 0.0001, Tukey’s) and 18 months old (p < 0.0001, Tukey’s) (Fig. 1 B1). The 290 
frequency of spontaneous colonic contractions also changed significantly with age (p 291 
< 0.0001, one way ANOVA, N = 8 animals per age group). Post-hoc analysis revealed 292 
a significant increase in the frequency of spontaneous contractions between P 10 and 293 
P 15 (p < 0.0001, Tukey’s), P 10 and P 60 (p < 0.0001, Tukey’s) and P 10 and 18 294 
months (p < 0.0001, Tukey’s). There was also a significant increase between P 15 and 295 
P 60 (p < 0.0001, Tukey’s). However, there was no significant difference between P 296 
60 and 18 months (p = 0.1760, Tukey’s). Therefore, the changes observed in the 297 
longitudinal spontaneous colonic contractility were mostly associated with 298 
developmental stages rather than ageing during adulthood.  299 
 300 
We have previously demonstrated that in adult mice (P 60), the benzodiazepine 301 
alprazolam, which is likely to positively allosterically modulate α1-3/5-γ2-β subunit-302 
containing GABAARs, significantly decreases the force of spontaneous colonic 303 
contractions (27). We therefore assessed whether this effect of colonic GABAAR 304 
activation persists at all ages. There was a significant interaction between the effect 305 
of alprazolam and age on the force of contractions (p = 0.003, two way ANOVA with 306 
repeated measures, N = 8 animals per age group). Post-hoc analysis revealed that 307 
alprazolam significantly decreased the force of contractions at P 10 (p <0.0001, 308 
Tukey's) and at P 60 (p <0.0001, Tukey's). However, this effect of alprazolam was not 309 




There was also a significant interaction between the effect of alprazolam and age on 312 
the frequency of contractions (p < 0.0001, two way ANOVA, N = 8 animals per age 313 
group). Post-hoc analysis revealed that alprazolam significantly increased the 314 
frequency of contractions at P 60 (p < 0.0001, Tukey’s). However, alprazolam had no 315 
significant effect at, P 10 (p > 0.9999), P 15 (p = 0.8786) and 18 months (p = 0.9735) 316 
(Fig. 1 B2). Alprazolam has also been shown to decrease the basal tone of the adult 317 
mouse colon (27), and demonstrated in Fig. 1 A. The current study revealed that this 318 
effect of GABAAR activation on colonic tone is significant at all ages compared to the 319 
baseline which was taken as zero (p < 0.0001, one way ANOVA, N = 8 animals per 320 
age group) (Fig. 1 B3). However, this relaxant effect of alprazolam on the colonic tone 321 
was significantly increased between P 15 to P 60 (P < 0.0001, Tukey’s) and 18 months 322 
old (p < 0.0001, Tukey’s). The pre-application of the benzodiazepine antagonist 323 
flumazenil (1 µM) abolished the contractile effects of alprazolam (Fig. 1 A, boxed 324 
trace), thus confirming that the effect of alprazolam is mediated via benzodiazepine 325 
sites on colonic GABAARs. This suggests that the modulation of spontaneous colonic 326 
contractility by the local GABAAR system, changes dynamically during early 327 
development extending into later adulthood.   328 
 329 
3.2 GABAAR subunit expression changes with age 330 
Given the contrasting functional effects of alprazolam on the mouse colon at different 331 
ages, we next explored whether the expression of these receptors might also vary with 332 
age, using qPCR to measure the mRNA expression of the α 1 – 5 and γ2 subunits, in 333 
homogenates containing all tissue layers of the colon. The α1 (p = 0.0003, ANOVA) 334 
(Fig. 2 A), α2 (p = 0.0025, ANOVA) (Fig. 2 B), α5 (p < 0.0001, ANOVA) (Fig. 2 E) and 335 
γ2 (p = 0.0001, ANOVA) (Fig. 2 F) subunits all exhibited a significant decrease in 336 
expression with age. In stark contrast, the α3 subunit showed a significant increase in 337 
expression with age (p = 0.0143, ANOVA) (Fig. 2 C). There were no significant 338 
differences between ages for the α4 subunit (p > 0.05, ANOVA) (Fig. 2 D). This 339 
indicates that GABAAR expression within the mouse colon is age and subunit specific. 340 
 341 
3.3 The GABAAR α3 subunit as a mediator of colonic inflammation in late adulthood  342 
Altered local immune function is a consequence of healthy ageing of the intestine (3, 343 
16). We have recently demonstrated that the GABAAR α3 subunit promotes stress-344 
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induced inflammation in the mouse colon (30). In light of the striking increase in the 345 
expression of the GABAAR α3 subunit at 18 months, we explored whether this subunit 346 
could be involved in age-related colonic inflammation. Firstly, we investigated the 347 
expression levels of inflammatory mediators in the colon of young adult (2 months) 348 
and older adult (18 months) WT mice. We then investigated this in age-matched older 349 
WT and α3 KO adult mice. Immunohistochemical analysis for CD163, within the ENS 350 
of the colon revealed a significant increase in expression between 2 and 18 months of 351 
age (Fig. 3). CD163 is a monocyte and M2 type macrophage-specific protein. Its 352 
upregulation constitutes one of the principal changes when macrophages switch to an 353 
activated phenotype following inflammation (37). Quantification of the density of 354 
CD163-immunopositive profiles revealed a significant increase between 2 and 18 355 
month old subjects, reacted and imaged under identical conditions (p < 0.0001, 356 
unpaired Student’s t test, N = 5) (Fig. 4 A). There was also a significant increase in the 357 
mRNA expression of CD163 with age (ANOVA, N = 6) (Fig. 4 B). Finally, there was a 358 
significant increase in the mRNA expression of another key marker of intestinal 359 
inflammation, tumour necrosis factor alpha (TNFα), at 18 months, compared to 360 
younger ages (ANOVA, N = 6) (Fig. 4 C).  361 
 362 
In order to investigate the possible link between the observed inflammation in older 363 
adult mice and GABAAR α3 subunit, we repeated these experiments in α3 KO mice. 364 
In comparative analyses using aged-matched (12 months) WT and α3 KO mice, 365 
whilst widespread CD163 immunoreactivity was evident in WT tissue, significantly 366 
lower levels were evident in tissue from α3 KO mice (Fig. 5). Quantification of the 367 
density of CD163-immunoreactive profiles revealed a significant difference between 368 
WT and α3 KO mice (p = 0.0002, unpaired Student’s t test, N = 6) (Fig. 6 A).  There 369 
was also a significant decrease in CD163 mRNA between WT and α3 KO mice (p = 370 
0.0001, unpaired Student’s t test, N = 6) (Fig. 6 B). Whilst the TNF α mRNA showed 371 
a trend towards decreased expression, this difference was not statistically significant 372 
(p = 0.5459, unpaired Student’s t test, N = 6) (Fig. 6 C). This suggests a possible 373 
role for the GABAAR α3 subunit in mediating the colonic inflammation associated 374 
with the process of ageing.   375 
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4 Discussion 376 
The data demonstrate that mouse longitudinal spontaneous colonic contractility 377 
patterns change significantly during early postnatal developmental stages but not from 378 
young to old adulthood. Furthermore, the effect of GABAAR activation on these 379 
contractions was age-dependent and the expression of GABAAR subunits changed 380 
dynamically in a subunit-specific and age-dependant manner. Finally, the deletion of 381 
the GABAAR α3 subunit prevented an increase in the expression of colonic 382 
inflammatory markers associated with healthy ageing. Collectively, the data provide 383 
the first demonstration of the molecular and functional plasticity of the GI GABAAR 384 
system over the course of a lifetime, and its possible role in mediating the age-induced 385 
colonic inflammation associated with healthy ageing.  386 
 387 
Central to ensuring optimal nutritional requirements, at different ages, is an intestinal 388 
motility pattern appropriate for the changes in diet that occur from the neonate through 389 
to the elderly. This study focussed on only one aspect of motility, namely, contractility 390 
of longitudinal smooth muscles. We have previously shown two different patterns of 391 
longitudinal contractions within the mouse colon. These include large spontaneous 392 
contractions superimposed on smaller, more frequent contractions (27). The data 393 
presented in this study are an average of both large and smaller spontaneous 394 
contractions together. This study shows that the pattern of these contractions changes 395 
significantly from P 10 to P 15 and onwards. This coincides with the age at which 396 
young mice open their eyes and start intake of solid food in addition to milk. 397 
Interestingly, previous studies have shown that myenteric neurons of the intestine 398 
undergo significant morphological and electrophysiological changes from P 10 to 399 
adulthood (38). Indeed, neurotransmitter systems such as dopaminergic and 400 
purinergic system undergo developmental changes shifting from contraction to 401 
relaxation just before and during weaning (39, 40). In addition, during these early 402 
postnatal days, the microbiota and immune cell community of the GIT are constantly 403 
changing (41, 42). Therefore, the altered pattern of colonic contractility at P15 may be 404 
the result of this changing landscape of GIT function during development. 405 
Furthermore, the process of ageing has been associated with drastic changes in GI 406 
motility and development of gastrointestinal disorder (17). Indeed, colonic motility has 407 
been shown to be impaired in aged (24 month old) mice (43). Since colonic motility 408 
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arises from the coordinated contractions and relaxations of the colonic smooth 409 
muscles, we therefore expected age-induced changes in the force of colonic 410 
spontaneous contractions. However, in the current study, we did not detect any 411 
significant changes in the force of spontaneous colonic contractions of 18 months old 412 
mice in comparison to young adults. The most likely explanation is the differences in 413 
the age of old mice used in the present study. In addition, methodological differences 414 
could also be a factor as we did not measure overall colonic motility per se, merely 415 
one contributor to motility, namely longitudinal muscle contractility. Nonetheless, 416 
numerous studies (4, 17, 43) have suggested that changes in the neurotransmitter 417 
systems of the ENS are a contributing factor to the developmental and the age-418 
induced decline in GI motility. However, it is important to note that mucosal signalling 419 
through the 5-HT system has also been shown to play an important role in age-induced 420 
changes in GI motility (44).  421 
 422 
In the present study, we focussed on investigating the expression and function of the 423 
enteric GABA-GABAAR system during development and at different ages. Here, we 424 
show that the relaxant effect of alprazolam on the spontaneous colonic contractions is 425 
significant at P 60 and P 10, but not P 15 or 18 months old. Furthermore, alprazolam 426 
was only able to significantly alter the frequency of colonic longitudinal spontaneous 427 
contraction at P 60. An explanation for this could be differences in the amount of 428 
GABAARs expressed at various ages. However, we only observed significantly higher 429 
levels of GABAARs expression at P10, with no significant differences between P 15, P 430 
60 and 18 months old. Another likely explanation could be differences in the amount 431 
of ambient tonic GABA within the ENS and GIT. Since alprazolam is a benzodiazepine, 432 
it will induce an effect only if local GABA is already bound to the receptor. Therefore, 433 
differences in the endogenous extracellular GABA within the gut at different ages will 434 
likely impact on the overall effect of alprazolam on colonic contractility. Importantly, 435 
ageing induced decline in GABA concentration have been previously shown within the 436 
brain (45). This could in turn impact on the regulation of ENS GABAAR numbers, and 437 
thus GABAAR-mediated colonic function. Therefore, future studies focussed on 438 
characterising the changes in enteric GABAergic neurons, extracellular GABA 439 
concentrations and GABAAR subtype expression, across ages, could reveal novel 440 
insights into gut homeostasis and how this is impaired in age-specific gut dysfunction, 441 
such as GI inflammation in the elderly. 442 
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The most striking finding was that the majority of the GABAAR subunits examined 443 
showed the highest levels of expression at early postnatal ages. This suggests a 444 
potential role for this system in development of the ENS and the GIT. This is not 445 
surprising as the GABA-GABAAR system is implicated in the development of the CNS. 446 
In early postnatal stages of the brain, GABA, signalling via GABAARs, is thought to 447 
have a depolarising effect on postsynaptic membranes due to the relatively high 448 
concentration of intracellular chloride ions (46). It is postulated that this initial excitatory 449 
effect of GABAARs makes major a contribution to the development of brain circuitry 450 
prior to the development of glutamate inputs (47). In contrast to the CNS, GABA is 451 
generally considered to be predominantly excitatory in the ENS (19), thereby indicating 452 
a potential role as a modulator of neural circuitry development. Furthermore, the 453 
highest levels of intestinal GABA expression, in rat at least, are detected at early 454 
developmental stages (48). The earliest age we examined was P 10, by which stage, 455 
a significant degree of development of the ENS would have already ensued (49). It 456 
would therefore be useful to examine GABAAR subunit expression possibly at 457 
embryonic or earlier postnatal stages to determine whether a changing landscape of 458 
the GABAAR system coincides with specific developmental time points of the ENS. 459 
Coupled with functional analysis using GABAAR subunit-specific knockout mice, such 460 
studies might allow for the possible exploitation of this neurotransmitters system in 461 
medical conditions associated with impaired development of the ENS, such as 462 
Hirschsprung's disease (50). 463 
 464 
Numerous studies have shown developmental and age-induced alteration in the 465 
expression and function of GABAARs within the CNS, in a subunit, brain region and 466 
disease specific manner (51-54). In this study, we provide the first demonstration of 467 
such changes in the expression of GABAARs within the GIT. Interestingly, in contrast 468 
to all other subunits examined which showed a decreasing trajectory of expression 469 
with age, the GABAAR α3 subunit exhibited an expression profile that increased, 470 
exclusively in late adulthood (18 months). In conjunction with this, we also observed a 471 
significant increase in the expression of inflammatory markers in late adulthood (18 472 
months).  This is important, as we have recently shown that the activation of colonic 473 
GABAAR α3 subunit induces inflammation and plays a direct role in stress-induced GI 474 
inflammation (30). Furthermore, other studies have also shown that activation of 475 
colonic GABAARs exacerbates acute colitis (55). Therefore, our data suggests that 476 
17 
 
GABAAR α3 subunit may play a role in mediating age-related increase in colonic 477 
inflammation. Remarkably, the deletion of this subunit prevented the increase in the 478 
expression of colonic inflammatory markers in 12 months old mice. Although 12 479 
months old mice may not be classified as aged mice, this data suggests an important 480 
role for the GABAAR α3 subunit as a potential contributor to age-induced GI disorders 481 
associated with immune dysfunction. There is a disproportionate prevalence of GI 482 
disorders in the elderly, compared to younger individuals (3, 56). Whilst the underlying 483 
changes are complex, a consistent finding is alterations in the local immune system, 484 
manifesting in increased infections and inflammation (31). Therefore, further 485 
investigations of the role of GABAAR α3 subunit as potential target for the treatment of 486 
GI inflammatory disorders in the elderly, could provide novel therapeutics for 487 
alleviation of associated symptoms. The other associated GABAAR subtypes should 488 
not be overlooked, potentially as therapeutic targets for impaired GI immune function. 489 
Indeed, we have also demonstrated that the activation of α1/2 subunit-containing 490 
GABAARs induces an anti-inflammatory effect in the colon (30). Furthermore, the 491 
expression profiles across age of these subunits were diametrically opposite to that of 492 
the α3 subunit. Collectively, that data reveals a dynamic GI GABA-GABAAR system 493 
that adapts, over the course of a lifetime, to mediate various GI functions at different 494 
ages. This study also provides a platform for further investigation of the GABAAR 495 
system as potential therapeutic targets for the treatment of inflammatory disorders 496 
associated with ageing.  497 
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Figure 1 713 
Spontaneous and GABAAR-mediated colonic contractility is age dependent 714 
(A) representative traces demonstrating changes in the spontaneous longitudinal 715 
muscle contractions of mouse colon at different ages, in vitro, and their responses to 716 
the application of the benzodiazepine alprazolam 10 µM. The pre-application of the 717 
benzodiazepine antagonist flumazenil abolished the effect of alprazolam (boxed 718 
trace).   719 
(B) quantification of (B1) the force and (B2) the frequency of spontaneous longitudinal 720 
muscle contractions of mouse colon at different ages and how these parameters 721 
change in response to the application of 10 µM alprazolam. (B3) changes in the 722 
relaxant effect of alprazolam on colonic basal tone at different ages. Bars represent 723 
means and the lines represent the SEM. N = 8 animals, * P < 0.05, repeated measures 724 







Figure 2 730 
Colonic GABAAR subunit mRNA expression is age dependent 731 
(A-F) quantification of the mRNA expression levels of the GABAAR α 1-5 and γ2 732 
subunits respectively, in the mouse colon at different ages, relative to the 733 
housekeeping gene Gapdh, using qPCR. Bars represent means and the lines 734 










Figure 3 743 
Native colonic inflammation increases with age 744 
(A1) immunoreactivity for nitric oxide synthase (NOS), used to identify ENS plexuses 745 
in the colon of a mouse at 2 months of age. (A2) in the same field of view, 746 
immunoreactivity for CD163, a receptor expressed on activated monocytes and/or 747 
macrophages and thus a marker of inflammation. (A3) is an overlay of (A1 and A2).  748 
(B1) immunoreactivity for NOS in the colon of a mouse at 18 months of age, reacted 749 
and imaged under conditions identical to tissue from a 2 month old mouse. (B2) in the 750 
same field of view, immunoreactivity for CD163. Note the dramatic increase in the 751 
density of immunoreactive profiles indicating a significant age-dependent increase in 752 




Figure 4 755 
Quantification of the expression of inflammatory mediators in whole segments of the 756 
colon at different ages. 757 
(A) quantification of the density of CD163-immunoreactive profiles in the ENS of mice 758 
2 and 18 months of age. (B-C) quantification of the mRNA expression levels of CD163 759 
and TNFα respectively, in the colon of mice 2 and 18 months of age, relative to the 760 
housekeeping gene Gapdh, using qPCR. Bars represent means and the lines 761 
represent the SEM. N = 6 animals, * P < 0.05, unpaired Student’s t test and ANOVA 762 







Figure 5 766 
GABAAR α3 subunit deletion prevents age-dependent colonic inflammation 767 
(A1) immunoreactivity for NOS in the colon of a 12 month old wild type (WT) mouse. 768 
(A2) in the same field of view, immunoreactivity for CD163. (A3) is an overlay of (A1 769 
and A2). (B1) immunoreactivity for NOS in the colon of a 12 month old GABAAR α3 770 
subunit deleted (α3 KO) mouse, reacted and imaged under identical conditions to WT 771 
tissue. (B2) in the same field of view, immunoreactivity for CD163. Note the significant 772 
decrease in immunoreactive profiles indicating an absence of age-dependent colonic 773 
inflammation in the absence of the GABAAR α3 subunit. (B3) is an overlay of (B1 and 774 





Figure 6 778 
Quantification of the expression of inflammatory mediators in the colon of aged wild 779 
type and GABAAR α3 KO mice. 780 
(A) quantification of the density of CD163-immunoreactive profiles in the ENS of WT 781 
and α3 KO mice at 12 months of age. (B-C) quantification of the mRNA expression 782 
levels of CD163 and TNFα respectively, in the colon of WT and α3 KO mice at 12 783 
months of age, relative to the housekeeping gene Gapdh, using qPCR. Bars represent 784 
means and the lines represent the SEM. N = 6 animals, * P < 0.05, unpaired Student’s 785 
t test.  786 
